Testing an imaging drug to see tumors in children having surgery
Part of Cancer clinical trials.
This study tests a special imaging drug called pafolacianine (Cytalux) that helps doctors see tumors more clearly during surgery. It is for children and teens who have a solid tumor in the body and are already scheduled for tumor removal or biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 months and 17 years old.
- Your child must have a known or suspected solid tumor (like a sarcoma, neuroblastoma, or carcinoma) in the neck, chest, belly, pelvis, or an arm or leg, and surgery is planned to remove or biopsy it.
- Your child must not have received the study drug (Cytalux/pafolacianine) before.
- Your child must not have a known allergy to indocyanine green (a dye) or any part of Cytalux.
- If your child is able to become pregnant or get someone pregnant, they must be willing to use birth control or avoid sexual activity for 30 days after the study drug is given.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called pafolacianine (CYTALUX) that makes cancer cells glow during surgery. It may help doctors see and remove more cancer from the stomach, esophagus, or appendix. You take the drug before surgery, and a special camera shows the glowing cancer.
This study tests a special dye, called pafolacianine, that is injected before surgery to help surgeons see hidden cancer spots in the belly during the operation. The goal is to see if using this dye improves how completely the cancer is removed in people with gastrointestinal cancer that has spread to the belly lining.
This trial tests a dye called Cytalux that helps surgeons see cancer during surgery. You get the dye before surgery, and it makes cancer cells glow under a special light. This could help doctors remove more cancer.
This trial tests a dye called Cytalux (pafolacianine) to help surgeons see cancer during lung or ovarian cancer surgery. If you are scheduled for surgery to remove lung cancer or to debulk ovarian cancer, you may be eligible.
This study tests whether a dye called Cytalux, injected before lung surgery, can help surgeons see and remove cancer spots in children and teens with certain cancers. It may help make sure all visible cancer is removed during the operation.
This trial tests a dye (CYTALUX) that helps surgeons see endometrial cancer during surgery. You may be eligible if you have endometrial cancer and are scheduled for surgery.
Hear when a new Childhood Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.